{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:56:24Z","timestamp":1760550984625,"version":"3.41.2"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.01157","type":"journal-article","created":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T05:02:41Z","timestamp":1572584561000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Brain Atrophy in Relapsing Optic Neuritis Is Associated With Crion Phenotype"],"prefix":"10.3389","volume":"10","author":[{"given":"Laura Navarro","family":"Cant\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Carratal\u00e1","family":"Bosc\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen Alcal\u00e1","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Gil-Peront\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"P\u00e9rez-Miralles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica Castillo","family":"Villalba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Cubas","family":"Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonaventura","family":"Casanova Estruch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMcp053247","article-title":"Clinical practice. Optic neuritis","volume":"354","author":"Balcer","year":"2006","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1177\/1352458513510223","article-title":"Relapsing optic neuritis: a multicentre study of 62 patients","volume":"20","author":"Benoilid","year":"2014","journal-title":"Mult Scler."},{"key":"B3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/brain\/awg045","article-title":"Chronic relapsing inflammatory optic neuropathy (CRION)","volume":"126","author":"Kidd","year":"2003","journal-title":"Brain."},{"key":"B4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00415-013-6957-4","article-title":"Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported","volume":"261","author":"Petzold","year":"2014","journal-title":"J Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/jnnp.2008.146894","article-title":"Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis","volume":"81","author":"Petzold","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B6","first-page":"130","article-title":"Recurrent isolated optic neuritis: a study on 22 patients","volume":"16","author":"Arzani","year":"2017","journal-title":"Iran J Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","article-title":"The spectrum of MOG autoantibody-associated demyelinating diseases","volume":"9","author":"Reindl","year":"2013","journal-title":"Nat Rev Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1177\/1352458514555785","article-title":"Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease","volume":"21","author":"H\u00f6ftberger","year":"2015","journal-title":"Mult Scler."},{"key":"B10","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s00415-015-7983-1","article-title":"Isolated new onset \u2018atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up","volume":"263","author":"Piccolo","year":"2016","journal-title":"J Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s00415-016-8147-7","article-title":"Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes","volume":"263","author":"Sep\u00falveda","year":"2016","journal-title":"J Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1212\/NXI.0000000000000040","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis","volume":"1","author":"Ramanathan","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1212\/NXI.0000000000000131","article-title":"Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis","volume":"2","author":"Chalmoukou","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jns.2013.05.012","article-title":"Aquaporin-4 antibody negative recurrent isolated optic neuritis: clinical evidence for disease heterogeneity","volume":"331","author":"Waschbisch","year":"2013","journal-title":"J Neurol Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3109\/01658107.2015.1072726","article-title":"Clinical profile of anti-myelin oligodendrocyte glycoprotein antibody seropositive cases of optic neuritis","volume":"39","author":"Matsuda","year":"2015","journal-title":"Neuroophthalmology."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e007766","DOI":"10.1136\/bmjopen-2015-007766","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis","volume":"5","author":"Nakajima","year":"2015","journal-title":"BMJ Open."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1212\/NXI.0000000000000538","article-title":"Anti-MOG encephalitis mimicking small vessel CNS vasculitis","volume":"6","author":"Patterson","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1212\/NXI.0000000000000257","article-title":"Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis","volume":"3","author":"Spadaro","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3109\/00207454.2014.896912","article-title":"White matter involvement beyond the optic nerves in CRION as assessed by diffusion tensor imaging","volume":"125","author":"Colpak","year":"2015","journal-title":"Int J Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1136\/jnnp-2015-312304","article-title":"Automated brain volumetrics in multiple sclerosis: a step closer to clinical application","volume":"87","author":"Wang","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00234-019-02191-3","article-title":"Brain regional volume estimations with NeuroQuant and FIRST: a study in patients with a clinically isolated syndrome","volume":"61","author":"Pareto","year":"2019","journal-title":"Neuroradiology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1468-1331.2012.03867.x","article-title":"White matter volume is decreased in the brain of patients with neuromyelitis optica","volume":"20","author":"Chanson","year":"2013","journal-title":"Eur J Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1212\/WNL.53.8.1698","article-title":"Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple sclerosis collaborative research group","volume":"53","author":"Rudick","year":"1999","journal-title":"Neurology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1212\/01.WNL.0000036271.49066.06","article-title":"Eight-year follow-up study of brain atrophy in patients with MS","volume":"59","author":"Fisher","year":"2002","journal-title":"Neurology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/WCO.0000000000000446","article-title":"Myelin oligodendrocyte glycoprotein antibodies: how clinically useful are they?","volume":"30","author":"Reindl","year":"2017","journal-title":"Curr Opin Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1590\/0004-282x20170121","article-title":"MOG-IgG associated optic neuritis is not multiple sclerosis","volume":"75","author":"Costa","year":"2017","journal-title":"Arq Neuropsiquiatr."},{"key":"B32","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12974-018-1335-x","article-title":"Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies","volume":"15","author":"Lee","year":"2018","journal-title":"J Neuroinflamm."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1111\/ene.13753","article-title":"Acute idiopathic optic neuritis: not always benign","volume":"25","author":"Deschamps","year":"2018","journal-title":"Eur J Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00415-017-8651-4","article-title":"Clinical characteristics of myelin oligodendrocyte glycoprotein seropositive optic neuritis: a cohort study in Shanghai, China","volume":"265","author":"Zhao","year":"2017","journal-title":"J Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jns.2005.03.006","article-title":"Steroids and brain atrophy in multiple sclerosis","volume":"233","author":"Zidavinov","year":"2005","journal-title":"J Neurol Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1212\/WNL.57.7.1239","article-title":"Effects of IV methylprednisolone on brain atrophy in relapsing\u2013remitting MS","volume":"57","author":"Zivadinov","year":"2001","journal-title":"Neurology."},{"key":"B37","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1212\/WNL.59.5.688","article-title":"Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFNbeta-1b","volume":"59","author":"Rao","year":"2002","journal-title":"Neurology."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01157\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T05:02:44Z","timestamp":1572584564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01157\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,1]]},"references-count":37,"alternative-id":["10.3389\/fneur.2019.01157"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.01157","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2019,11,1]]},"article-number":"1157"}}